Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations
- PMID: 15664565
- DOI: 10.1016/j.autneu.2004.11.005
Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations
Abstract
Background: Botulinum toxin type A (BoNT/A) is 20-50 times more effective than Botulinum toxin type B (BoNT/B) concerning the treatment of muscular hypercontractions [Sloop, R.R., Cole, B.A., Escutin, R.O., 1997. Human response to botulinum toxin injection: type B compared with type A. Neurology 49, 189-194]. Botulinum toxins block motor nerves as well as autonomic fibres [Rand, M.J., Whaler, B.C., 1965. Impairment of sympathetic transmission by botulinum toxin. Nature 206, 588-591].
Objective: Purpose of this study was to analyse the dose dependent reduction of sweating using the BoNT/A preparation Botox and to compare the results with our earlier results analysing Dysport [Braune, C., Erbguth, F., Birklein, F., 2001. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry. Br. J. Dermatol. 144, 111-117] and Neurobloc (BoNT/B) [Birklein, F., Eisenbarth, G., Erbguth, F., Winterholler, M., 2003. Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up. J. Invest. Dermatol. 121, 1312-1316].
Methods: Different doses of Botox were injected subcutaneously (n=27 healthy subjects). Planimetrical analyses of the area of anhidrosis and quantitative sudomotor-axon-reflex testing (QSART) were done after 3 weeks, 3 and 6 months.
Results: A threshold dose of 1.25 MU Botox led to anhidrotic skin spots after 3 weeks. The duration of anhidrosis was prolonged for 3 months when 17.5 MU and for 6 months when 50 MU were injected. Anhidrotic area size decreased with time (p=0.001), indicating partial recovery at the edges. After 3 weeks, QSART had significantly decreased to 29% of baseline. With doses of 70 MU or more it decreased to zero. After 3 months, QSART had returned to 68% of baseline and after 6 months to 87%.
Conclusions: Botox dose-dependently suppressed sweating. Comparison to Dysport and Neurobloc revealed a strikingly similar efficacy after 3 weeks and 3 months for all preparations. BoNT/A in general induced a more sustained anhidrosis than BoNT/B.
Similar articles
-
Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.Br J Dermatol. 2001 Jan;144(1):111-7. doi: 10.1046/j.1365-2133.2001.03961.x. Br J Dermatol. 2001. PMID: 11167691
-
Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.J Invest Dermatol. 2003 Dec;121(6):1312-6. doi: 10.1046/j.1523-1747.2003.12620.x. J Invest Dermatol. 2003. PMID: 14675175 Clinical Trial.
-
Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.Dermatol Surg. 2006 Jul;32(7):886-90. doi: 10.1111/j.1524-4725.2006.32191.x. Dermatol Surg. 2006. PMID: 16875469 Clinical Trial.
-
Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.J Drugs Dermatol. 2011 Sep;10(9):1013-5. J Drugs Dermatol. 2011. PMID: 22052270 Review.
-
Pharmacology of botulinum toxin: differences between type A preparations.Eur J Neurol. 2006 Feb;13 Suppl 1:2-10. doi: 10.1111/j.1468-1331.2006.01438.x. Eur J Neurol. 2006. PMID: 16417591 Review.
Cited by
-
Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.Drug Saf. 2008;31(2):109-26. doi: 10.2165/00002018-200831020-00002. Drug Saf. 2008. PMID: 18217788 Review.
-
Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis.PLoS One. 2014 Sep 29;9(9):e108525. doi: 10.1371/journal.pone.0108525. eCollection 2014. PLoS One. 2014. PMID: 25265022 Free PMC article.
-
In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin.Br J Pharmacol. 2006 Jan;147(2):183-7. doi: 10.1038/sj.bjp.0706451. Br J Pharmacol. 2006. PMID: 16273117 Free PMC article.
-
[Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].Schmerz. 2012 Apr;26(2):176-84. doi: 10.1007/s00482-011-1140-2. Schmerz. 2012. PMID: 22527647 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials